2GELDERBLOM H, VERWEI J J, NOOTER K,et al. The drawbacks and advantages of vehicle selection for drug formulation [ J ]. Eur J Cancer,2001,37(13) :1590.
3ABU-KHALAF M M, JUNEJ A V, CHUNG G G,et al. Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T) , and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer [J]. Breast Cancer Res Treat.2007.104 (3) ,341.
4ARMSTRONG D K, BOOKMAN M A, MCGUIRE W,et al. A phase I study of paclitaxel, topotecan, cisplatin and filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study [ J ]. Gynecol Oncol, 2007, 105 (3) :667.
5PERKINS C L, FANG G, KIM C N. The role of Apaf-1, caspase-9, and bid proteins in etoposide-or paclitaxel-induced mitochondrial events during apoptosis[ J]. Cancer Res,2000,60 (6) :1645.
6SYMMANS W F, VOLOM M D, SHAPIRO R L, et al. Paclitaxelinduced apoptosis and mitotic arrest assessed by serial fine-needle aspiration : implications for early prediction of breast cancer response to neoadjuvant treatment[J]. Clin Cancer Res,2000 ,6 (12) :4610.
7KLAUBER N, PARANGI S, FLYNN E, et al. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2- methoxyestradiol and taxol [ J ]. Cancer Res, 1997,57 ( 1 ) : 81.
8PARK D C, KI J H, LEW Y O, et al. Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer[ J ]. Gynecol Oncol, 92(1) :59.
9DAVID H, MOORE J A,BLESSING R P,et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study [ J ]. J Clin Oncol, 2004,22 ( 15 ) : 3113.
10BUDA A , ROLDANO F, NICOLETTA C,et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study [ J]. J Clin Oncol,2005,23(18) :4137.
